DCGI nod to Serum-Oxford covid-19 vaccine for phase 2, 3 clinical trials in India
Posted by
www.biotecnika.org
According to the proposal, 1,600 people will participate in the trials
across 20 cities in the country, the health and family welfare
ministry said in a release on Monday.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/serum-gets-dcgi-nod-for-oxford-vaccine-trials/articleshow/77337121.cms
Subscribe to:
Post Comments (Atom)
Post a Comment